ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 42 filers reported holding ONCOMED PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,000 | 0.0% | 2,270 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -96.7% | 2,270 | -92.1% | 0.00% | – |
| Q3 2018 | $61,000 | -10.3% | 28,644 | -2.6% | 0.00% | – |
| Q2 2018 | $68,000 | -22.7% | 29,399 | +6.3% | 0.00% | – |
| Q1 2018 | $88,000 | -25.4% | 27,649 | -3.6% | 0.00% | – |
| Q4 2017 | $118,000 | +490.0% | 28,686 | +538.9% | 0.00% | – |
| Q3 2017 | $20,000 | -42.9% | 4,490 | -57.5% | 0.00% | – |
| Q2 2017 | $35,000 | -92.2% | 10,574 | -78.2% | 0.00% | – |
| Q1 2017 | $446,000 | +197.3% | 48,477 | +148.6% | 0.00% | – |
| Q4 2016 | $150,000 | -73.5% | 19,500 | -60.6% | 0.00% | – |
| Q3 2016 | $566,000 | +265.2% | 49,536 | +292.3% | 0.00% | – |
| Q2 2016 | $155,000 | 0.0% | 12,626 | -17.2% | 0.00% | – |
| Q1 2016 | $155,000 | -98.3% | 15,255 | -96.2% | 0.00% | -100.0% |
| Q4 2015 | $8,983,000 | +65.3% | 398,494 | +21.7% | 0.00% | +100.0% |
| Q3 2015 | $5,435,000 | +1194.0% | 327,552 | +1655.2% | 0.00% | – |
| Q2 2015 | $420,000 | +1066.7% | 18,662 | +1258.2% | 0.00% | – |
| Q1 2015 | $36,000 | +140.0% | 1,374 | +100.0% | 0.00% | – |
| Q4 2014 | $15,000 | +36.4% | 687 | +17.6% | 0.00% | – |
| Q3 2014 | $11,000 | -47.6% | 584 | -35.1% | 0.00% | – |
| Q2 2014 | $21,000 | +40.0% | 900 | +98.2% | 0.00% | – |
| Q1 2014 | $15,000 | +66.7% | 454 | +49.3% | 0.00% | – |
| Q4 2013 | $9,000 | -91.0% | 304 | -95.3% | 0.00% | – |
| Q3 2013 | $100,000 | – | 6,502 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|